We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
-6.94%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$33.6B
AUM Growth
-$4.11B
(-11%)
Cap. Flow
-$868M
Cap. Flow
% of AUM
-2.58%
Top 10 Holdings %
Top 10 Hldgs %
23.36%
Holding
1,444
New
70
Increased
662
Reduced
591
Closed
59
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$174M |
| 2 |
Applied Materials
AMAT
|
+$106M |
| 3 |
Fortinet
FTNT
|
+$93.1M |
| 4 |
Comcast
CMCSA
|
+$92.9M |
| 5 |
Valaris
VAL
|
+$91.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
K
Kellanova
K
|
+$115M |
| 2 |
SLB Ltd
SLB
|
+$106M |
| 3 |
Campbell Soup
CPB
|
+$105M |
| 4 |
Merck
MRK
|
+$105M |
| 5 |
Constellation Brands
STZ
|
+$100M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 33.63% |
| 2 | Technology | 27% |
| 3 | Energy | 8.42% |
| 4 | Healthcare | 7.19% |
| 5 | Financials | 5.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Prospect Capital
PSEC
$1.11B
| $19.8M | 0.06% |
3,192,680
-238,443
| -7% | -$1.78M |
|
|
DTP
227
DELISTED
DTE Energy Company 2019 Corporate Units
DTP
| $19.5M | 0.06% |
389,750
+42,918
| +12% | +$2.2M |
|
228
Hercules Capital
HTGC
$3.16B
| $19.5M | 0.06% |
1,681,943
-98,967
| -6% | -$1.41M |
|
229
Nike
NKE
$63.2B
| $19.4M | 0.06% |
233,921
+8,918
| +4% | +$960K |
|
230
Illumina
ILMN
$30.1B
| $19.2M | 0.06% |
103,441
-1,351
| -1% | -$267K |
|
|
SVM
231
Silvercorp Metals
SVM
$2.1B
| $19M | 0.06% |
8,172,672
-10,488,127
| -56% | -$25.2M |
|
232
Teva Pharmaceuticals
TEVA
$39.8B
| $18.5M | 0.06% |
2,294,442
-919,292
| -29% | -$8.13M |
|
233
Helix Energy Solutions
HLX
$1.36B
| $18.5M | 0.06% |
4,789,122
-3,088,785
| -39% | -$11.7M |
|
234
Goldman Sachs BDC
GSBD
$991M
| $18.3M | 0.05% |
1,269,612
-108,601
| -8% | -$1.84M |
|
235
American Tower
AMT
$80.1B
| $18.3M | 0.05% |
85,383
+6,086
| +8% | +$1.56M |
|
236
Annaly Capital Management
NLY
$17.2B
| $18.3M | 0.05% |
1,067,349
+86,016
| +9% | +$2.17M |
|
237
IQVIA
IQV
$38.4B
| $18.3M | 0.05% |
100,996
-2,681
| -3% | -$587K |
|
238
Elanco Animal Health
ELAN
$12.7B
| $17.9M | 0.05% |
1,440,197
-475,506
| -25% | -$8.31M |
|
239
Southern Company
SO
$107B
| $17.6M | 0.05% |
258,835
-7,357
| -3% | -$557K |
|
240
argenx
ARGX
$52B
| $17.6M | 0.05% |
+49,717
| New | +$18.4M |
|
241
Plug Power
PLUG
$2.87B
| $17.5M | 0.05% |
831,685
-136,895
| -14% | -$3.26M |
|
242
Bilibili
BILI
$8.12B
| $17.4M | 0.05% |
1,138,542
+133,751
| +13% | +$3.05M |
|
243
Target
TGT
$67.9B
| $17.4M | 0.05% |
117,095
-4,537
| -4% | -$726K |
|
244
TJX Companies
TJX
$173B
| $17.2M | 0.05% |
277,016
+6,865
| +3% | +$431K |
|
245
Viatris
VTRS
$20.4B
| $17M | 0.05% |
1,997,562
-299,610
| -13% | -$2.95M |
|
246
BioNTech
BNTX
$23.5B
| $16.7M | 0.05% |
123,961
-11,137
| -8% | -$1.7M |
|
247
Core Laboratories
CLB
$488M
| $16.7M | 0.05% |
1,237,229
-680,249
| -35% | -$11.5M |
|
248
Sixth Street Specialty
TSLX
$1.69B
| $16.6M | 0.05% |
1,017,218
-25,397
| -2% | -$473K |
|
249
Lockheed Martin
LMT
$135B
| $16.4M | 0.05% |
42,577
+3,510
| +9% | +$1.47M |
|
250
Duke Energy
DUK
$96.6B
| $16.4M | 0.05% |
176,216
-39,426
| -18% | -$4.23M |
|
Similar funds
VanEck Associates's Q3 2022 Portfolio in Review
As of Q3 2022, VanEck Associates held 1,444 positions worth $33.6B, down 11% from $37.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
VanEck Associates's Q3 2022 filing shows 70 new, 662 increased, 591 reduced and 59 closed positions. Its largest new stake was Valaris: 1,902,492 shares worth $93.1M. The largest sale was Kellanova, an estimated $115M.
By sector, the portfolio is most concentrated in Materials at 34% of assets, down from 34% a quarter earlier, followed by Technology and Energy.
- VanEck Associates's largest Q3 2022 buy was Valaris: 1,902,492 shares worth $93.1M.
- VanEck Associates added most to NVIDIA in Q3 2022, an estimated $174M increase.
- VanEck Associates's biggest Q3 2022 reduction was Kellanova, cutting an estimated $115M.
- VanEck Associates fully exited CoStar Group in Q3 2022, selling an estimated $86.7M.
- VanEck Associates's ten largest holdings make up 23% of its $33.6B portfolio in Q3 2022.
- VanEck Associates opened 70 new positions and closed 59 in Q3 2022.
- VanEck Associates's portfolio value fell 11% quarter-over-quarter to $33.6B.
Based on VanEck Associates's 13F filing for Q3 2022, filed 27 Oct 2022.